Sulforaphane promoted demethylation at the NRF2 promoter region, which leads to the activation of Nrf2 expression in Caco2 cells, suggesting the chemoprevention potential of sulforaphane in colon cancer [139]. This evidence concerns the gene NFE2L2 and malignant colon neoplasm.